Intracranial Aneurysm

Global Intracranial Aneurysm Market to Reach US$2.8 Billion by 2030

The global market for Intracranial Aneurysm estimated at US$1.6 Billion in the year 2023, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Flow Diverters segment is estimated at 11.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$409.9 Million While China is Forecast to Grow at 12.4% CAGR

The Intracranial Aneurysm market in the U.S. is estimated at US$409.9 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$690.6 Million by the year 2030 trailing a CAGR of 12.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Intracranial Aneurysm Market - Key Trends and Drivers Summarized

How Are Advances in Treating Intracranial Aneurysms Transforming Patient Outcomes?

Intracranial aneurysms are abnormal bulges in the blood vessels of the brain that can lead to life-threatening conditions if they rupture. As medical technologies evolve, the treatment of intracranial aneurysms is advancing through minimally invasive techniques and cutting-edge devices, improving the prognosis for patients. Coiling, stent-assisted coiling, and flow diversion are among the primary interventions used to treat intracranial aneurysms today. These procedures are designed to prevent aneurysm rupture by reinforcing the walls of blood vessels, thereby significantly reducing the risk of hemorrhage. The increasing use of 3D imaging and intraoperative navigation systems is enhancing the precision of these treatments, allowing for better outcomes and reducing complications.

What Technological Advancements Are Shaping the Intracranial Aneurysm Market?

Technological innovations are transforming the diagnosis and treatment of intracranial aneurysms. Advances in neuroimaging techniques, such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA), are improving the early detection of aneurysms, which is critical for preventing rupture. Minimally invasive techniques, such as endovascular coiling and flow-diverting stents, are becoming the standard of care due to their ability to treat complex aneurysms with less trauma and shorter recovery times compared to traditional surgery. The development of bioactive and hydrogel-coated coils has further enhanced the durability of aneurysm occlusion, making treatment more effective and reducing the likelihood of recurrence.

How Do Market Segments Define the Growth of Intracranial Aneurysm Treatment?

Types of aneurysms include saccular, fusiform, and dissecting aneurysms, with saccular aneurysms being the most common and most frequently treated. Treatment approaches range from surgical clipping to minimally invasive endovascular coiling and flow diversion, with endovascular treatments dominating the market due to their lower risk profile and quicker recovery times. End-users of these treatments include hospitals, specialty clinics, and ambulatory surgical centers, with hospitals accounting for the largest share due to the complex nature of these procedures and the need for specialized equipment and expertise. The market is growing rapidly in developed regions such as North America and Europe, where healthcare infrastructure supports advanced neurological interventions.

What Factors Are Driving the Growth in the Intracranial Aneurysm Market?

The growth in the intracranial aneurysm market is driven by several factors, including the increasing prevalence of brain aneurysms, advancements in neuroimaging and endovascular techniques, and the rising demand for minimally invasive procedures. As the global population ages, the incidence of intracranial aneurysms is expected to rise, increasing the demand for effective treatment options. Technological innovations, such as 3D imaging and flow-diverting stents, are further propelling market growth by offering more precise and less invasive treatment options. Additionally, the growing awareness of aneurysm screening and the increasing availability of specialized neurological centers are contributing to the expansion of the market.

Select Competitors (Total 36 Featured) -

• B. Braun Melsungen AG
• Integra LifeSciences Corporation
• Johnson & Johnson
• Medtronic
• MicroPort Scientific Corporation
• Raumedic AG
• Stryker
• Terumo Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.